Collectively, these adaptations highlight exercise-driven remodulating of CD8+ T cell phenotypes as a pivotal mechanism mitigating chronic immune-mediated liver injury in NASH 112 (Figure 5C). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.